title: Early onset endophthalmitis caused by Aspergillus species following cataract surgery.
abstract: OBJECTIVE
  To report a series of patients with early onset Aspergillus endophthalmitis following cataract surgery.
  
  
  METHODS
  Retrospective consecutive case series.
  
  
  METHODS
  Medical records were reviewed of all cases of endophthalmitis caused by Aspergillus after cataract surgery treated at the authors' practices between 1992 and 2005.
  
  
  RESULTS
  Five patients were identified. Two patients were immunocompromised (one on oral corticosteroids and one on chemotherapy for lung cancer). The mean number of days between cataract surgery and diagnosis with endophthalmitis was 29 (range, 10 to 62 days). Three eyes (60%) were enucleated despite a variety of treatments. In addition to vitrectomy and injection of antifungal agents, the other two eyes underwent surgical debridement of a localized necrotic nidus. Final visual acuity was 20/30 in one eye and 20/200 in the remaining eye.
  
  
  CONCLUSIONS
  Aspergillus should be considered in the differential diagnosis of early onset endophthalmitis following cataract surgery. Visual outcomes are generally poor and enucleation is common in these patients.
authors.affiliation: Texas Retina Associates, Dallas, Texas, USA. dcallanan@texasretina.com
authors.forename: David
authors.initials: D
authors.lastname: Callanan
authors.forename: Ingrid U
authors.initials: IU
authors.lastname: Scott
authors.forename: Timothy G
authors.initials: TG
authors.lastname: Murray
authors.forename: Karen W
authors.initials: KW
authors.lastname: Oxford
authors.forename: C Bradley
authors.initials: CB
authors.lastname: Bowman
authors.forename: Harry W
authors.initials: HW
authors.lastname: Flynn
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D001230:Aspergillus / Q000302:isolation & purification*; D003646:Debridement; D009877:Endophthalmitis / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D015353:Eye Enucleation; D015821:Eye Infections, Fungal / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D005260:Female; D006801:Humans; D019654:Lens Implantation, Intraocular; D018918:Phacoemulsification / Q000009:adverse effects*; D011183:Postoperative Complications; D012189:Retrospective Studies; D014792:Visual Acuity; D014821:Vitrectomy
chemical_list: D000935:Antifungal Agents